[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.130.145. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 82
Citations 0
Letters
January 11, 2012

Supplementation in Acute Lung Injury—Reply

Author Affiliations

Author Affiliations: Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (Drs Rice and Wheeler) (todd.rice@vanderbilt.edu); and Pulmonary and Critical Care Unit, Massachusetts General Hospital, Boston, Massachusetts (Dr Thompson).

JAMA. 2012;307(2):144-146. doi:10.1001/jama.2011.1985

In Reply: The Randomized Trial of Omega-3 Fatty Acids on Top of Modern Therapy After Acute Myocardial Infarction (OMEGA) and the Early Versus Delayed Enteral Nutrition in ALI (EDEN) trial were designed to simultaneously investigate 2 questions regarding enteral nutrition in patients with ALI—the role of n-3 fatty acids, GLA, and antioxidant supplementation, and the risks and benefits of higher and lower volumes of enteral nutrition, respectively.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×